VINTOR 6000 IU INJECTION

Vintor 6000IU injection combines active components like Recombinant human erythropoietin Alfa/Ep. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). The medication is used to treat anemia that is caused by chronic kidney diseases (CKD), as well as chemotherapy for cancer or HIV treatment with zidovudine. It also reduces the requirement for transfusions of red blood cells in those at risk of blood loss as a result of planned surgery and other surgical procedures.
Vintor 6000IU injections are not recommended for those who are hypersensitive towards it or its constituents, uncontrolled hypertension, active thrombotic microangiopathy (TMA), Pure red cell cancer (PRCA) seizures that are not controlled, and pregnancy or lactation. Also, it should be used with caution in patients with a previous history of blood clots or heart disease, kidney disease, stroke thalassemia, liver disease, sickle cell anemia(SCA), myelodysplastic syndrome, leukemia, or cancer. It is recommended only for children younger than 18 when the benefits outweigh the risks. Older patients should be carefully monitored for any adverse effects. Before you begin this treatment, you must speak with your physician about the potential risks and benefits of Vintor infusions of 6000IU.